Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates

分组1 - Quest Diagnostics reported quarterly earnings of $2.30 per share, exceeding the Zacks Consensus Estimate of $2.26 per share, and showing an increase from $2.22 per share a year ago, representing an earnings surprise of 1.77% [1] - The company generated revenues of $2.49 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 3.36%, and up from $2.3 billion in the same quarter last year [1] - Over the last four quarters, Quest Diagnostics has consistently surpassed consensus EPS and revenue estimates [1] 分组2 - The stock has added approximately 6.9% since the beginning of the year, underperforming compared to the S&P 500's gain of 22.7% [2] - The current consensus EPS estimate for the upcoming quarter is $2.22 on revenues of $2.46 billion, and for the current fiscal year, it is $8.89 on revenues of $9.63 billion [4] - The Medical - Outpatient and Home Healthcare industry, to which Quest Diagnostics belongs, is currently ranked in the top 10% of over 250 Zacks industries, indicating a favorable outlook for the sector [5]